Here's my summary of key studies presented Tuesday.
Tofacitinib in Polyarticular JIA
The Medscape’s Physician Lifestyle & Happiness Report 2019 crowned rheumatologists as the happiest subspecialists. We topped the list with 65% of the respondents indicating that they were happy outside of work.
At the 2019 ACR Annual Meeting in Atlanta, almost 500 presentations discussed new randomized controlled trials (RCTs). We are lucky to have so much research activity in our field, but applying an RCT to your daily practice can be challenging.
“If exercise could be purchased in a pill, it would be the single most widely prescribed and beneficial medicine in the nation.” —Robert H. Butler, MD, first director of the National Institute on Aging.
This meeting sees new data on using anti-IL-17 agents in non-radiographic axial SpA. Up until now these patients have only had TNF inhibitors available, so data about the efficacy of IL17 inhibitors is really important.